Sjögren’s Syndrome

Understanding Sjögren’s Syndrome and the Importance of Clinical Research Participation

What Is Sjögren’s Syndrome? A Chronic Autoimmune Disease Affecting Moisture-Producing Glands

Sjögren’s syndrome is a chronic autoimmune condition in which the immune system attacks the body’s moisture-producing glands — primarily the salivary and tear glands — leading to symptoms of dry mouth and dry eyes. However, the condition can also affect other parts of the body, including joints, lungs, kidneys, nerves, skin, and gastrointestinal system.

Sjögren’s syndrome may occur alone (primary Sjögren’s) or in combination with other autoimmune diseases such as rheumatoid arthritis or lupus (secondary Sjögren’s). It affects an estimated 3 to 4 million people in the United States, with women representing the vast majority of those diagnosed — typically between the ages of 40 and 60.

Because its symptoms can mimic other conditions, Sjögren’s is often underdiagnosed or misdiagnosed. Clinical research plays a critical role in improving detection methods, exploring new treatments, and uncovering the biological underpinnings of this complex condition.

Symptoms of Sjögren’s Syndrome

Sjögren’s syndrome presents with a wide range of symptoms, from mild dryness to systemic complications. The most common and earliest signs involve mucosal dryness, but other immune-mediated symptoms may develop over time.

Common Symptoms Include:

  • Dry Eyes (Keratoconjunctivitis Sicca): Gritty, burning, or stinging sensation in the eyes

  • Dry Mouth (Xerostomia): Difficulty swallowing, speaking, or chewing; increased dental issues

  • Swollen Salivary Glands: Often under the jaw or in front of the ears

  • Joint Pain or Stiffness: Especially in the hands or knees

  • Fatigue: Persistent and often severe

  • Dry Skin or Vaginal Dryness

  • Persistent Cough or Shortness of Breath

  • Peripheral Neuropathy: Numbness or tingling in hands and feet

  • Digestive Symptoms: Bloating, cramping, or acid reflux

Because of its systemic nature, Sjögren’s can significantly impact quality of life, especially when it leads to complications such as lung disease, kidney dysfunction, or lymphoma.

Diagnosing Sjögren’s Syndrome

Sjögren’s is notoriously difficult to diagnose due to its overlap with other autoimmune conditions and its varied presentation. Diagnosis often requires a multidisciplinary approach and a combination of clinical, laboratory, and imaging findings.

Diagnostic Tools Include:

  • Blood Tests:

    • Anti-SSA (Ro) and Anti-SSB (La) antibodies

    • ANA, RF, and elevated inflammatory markers

  • Schirmer’s Test: Measures tear production using paper strips

  • Salivary Flow Tests: Assesses saliva output

  • Salivary Gland Imaging: Ultrasound or sialography to detect inflammation or structural damage

  • Minor Salivary Gland Biopsy: Taken from the inner lip to identify lymphocytic infiltration

Clinical trials often offer access to more advanced immune profiling, imaging, and disease activity scoring tools to better characterize disease subtypes.

Treatment Options for Sjögren’s Syndrome

There is currently no cure for Sjögren’s syndrome, and treatment focuses on relieving symptoms, preventing complications, and managing systemic involvement. Because each patient’s experience is different, individualized care is essential.

Treatment Strategies Include:

  • Symptom Relief for Dryness:

    • Artificial tears and eye ointments

    • Saliva substitutes, sugar-free lozenges, and prescription salivary stimulants

    • Topical lubricants for skin and vaginal dryness

  • Anti-inflammatory and Immunosuppressive Medications:

    • Hydroxychloroquine for fatigue and joint symptoms

    • Corticosteroids or immunosuppressants in cases with organ involvement

  • Biologic Therapies:

    • Currently under investigation — targeting B cells, cytokines, and other immune factors

  • Antifungal and Antibiotic Mouth Rinses:

    • To reduce oral infections

  • Lifestyle and Preventative Care:

    • Regular dental checkups, hydration, and use of humidifiers

    • Diet and stress management can also reduce flare-ups

New clinical trials are exploring precision therapies that address the underlying immune dysregulation in Sjögren’s, especially in patients with severe extraglandular symptoms.

RA management requires a comprehensive and individualized approach. The goal is to reduce inflammation, relieve symptoms, prevent joint and organ damage, and maintain long-term mobility.

RA Treatment Options Include:

  • Disease-Modifying Antirheumatic Drugs (DMARDs):

     

    • Methotrexate, Leflunomide, and others to slow disease progression

       

  • Biologic Agents:

     

    • TNF inhibitors (e.g., adalimumab, etanercept)

       

    • IL-6 inhibitors (e.g., tocilizumab)

       

    • B-cell and T-cell targeted therapies

       

  • Janus Kinase (JAK) Inhibitors:

     

    • A newer class of oral drugs for moderate-to-severe RA

       

  • NSAIDs and Corticosteroids:

     

    • To reduce inflammation and manage pain during flares

       

  • Physical Therapy and Occupational Therapy:

     

    • To maintain mobility, reduce stiffness, and support daily functioning

       

  • Lifestyle Adjustments:

     

    • A balanced diet, gentle exercise, stress management, and smoking cessation can help improve outcomes

       

Ongoing research is focused on developing more targeted biologic therapies and identifying biomarkers to predict which treatments will work best for each individual.

The Role of Clinical Research in Sjögren’s Syndrome Treatment

Sjögren’s syndrome remains a challenging condition with limited treatment options and no FDA-approved disease-modifying therapies. Clinical research is essential for developing better diagnostics, discovering targeted therapies, and improving long-term outcomes for patients.

Why Participate in a Clinical Trial?

  • Access to Emerging Treatments: Especially those not available through standard care

  • Regular Medical Monitoring: Including lab tests, imaging, and expert assessments

  • Contribute to Medical Advancements: Help accelerate the discovery of better, more effective therapies

  • No-Cost Care: Study-related visits, medication, and testing are typically provided at no charge

  • Hope for the Future: Especially for patients with severe or treatment-resistant symptoms

Clinical trials may be especially beneficial for individuals who have secondary Sjögren’s or systemic complications.

How BioResearch Partner Supports Sjögren’s Syndrome Research

BioResearch Partner is proud to contribute to innovative research into Sjögren’s syndrome in the Miami region. We work closely with immunologists, rheumatologists, and research sponsors to advance treatment strategies for this underdiagnosed and misunderstood disease.

Why Join a Sjögren’s Trial with BioResearch Partner?

  • Experienced Research Teams: With expertise in autoimmune and systemic disorders

  • Patient-Centered Studies: Prioritizing safety, accessibility, and comfort

  • State-of-the-Art Diagnostics: Including salivary gland imaging, biopsy coordination, and immune profiling

  • Diverse Enrollment: Our trials reflect the full range of patient backgrounds for more representative data

  • Convenient Location: Located in Miami for easy access to our community and surrounding areas

We are committed to uncovering new therapies that offer real relief for those living with Sjögren’s syndrome.

BioResearch Partner is proud to be at the forefront of rheumatoid arthritis research in Miami. We collaborate with experienced rheumatologists and pharmaceutical sponsors to conduct safe, effective, and ethically sound clinical trials for RA and other autoimmune disorders.

Why Join an RA Trial with BioResearch Partner?

  • Specialized Research Teams: With deep knowledge in autoimmune and rheumatologic diseases

     

  • Patient-Centered Care: Our team prioritizes your comfort, safety, and informed consent

     

  • Advanced Diagnostic Tools: Including joint imaging, immune biomarkers, and personalized assessments

     

  • Inclusive Enrollment: We serve participants from all backgrounds and encourage diversity in research

     

  • Convenient South Florida Location: Easily accessible for patients across the Miami region

     

We are committed to expanding treatment options and helping improve the lives of people living with rheumatoid arthritis.

BioResearch Partner is committed to accelerating lupus research in Miami and beyond. We partner with rheumatologists, immunologists, and pharmaceutical sponsors to offer access to innovative clinical trials for people living with lupus and related autoimmune disorders.

Why Choose BioResearch Partner?

  • Expertise in Autoimmune Research: Our investigators understand the complexity of lupus
  • Compassionate, Personalized Care: Participants are treated with empathy, respect, and individualized attention
  • State-of-the-Art Facilities: Equipped to conduct immune and organ-function monitoring
  • Inclusive Enrollment Practices: We prioritize diversity to ensure research is representative of all populations
  • Convenient Location in Miami: Easily accessible for South Florida residents

We are driven by a mission to make research more accessible and meaningful — for patients, caregivers, and the future of immune health.

Ready to Participate in a Clinical Trial?

If you or someone you know is living with Sjögren’s syndrome and interested in exploring new treatment options, BioResearch Partner is currently enrolling participants in clinical research studies.

📞 Call: 833-489-4978
🌐 Visit: www.bioresearchpartner.com
📩 Email: info@bioresearchpartner.com

Become a BioResearch Partner

We welcome your questions and are happy to discuss how clinical trials work and whether participation is right for you. Complete our contact form or reach out directly — your journey toward better care starts here.

Support the future of autoimmune care by joining a clinical research study with BioResearch Partner today.